Skip to content

H.R. 4780 · 119th Congress (2025–2027)

USTRx Act

This bill establishes the role of Chief Pharmaceutical Trade Negotiator within the Office of the U.S. Trade Representative (USTR). The negotiator must conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S. pharmaceutical manufacturers.

The USTR must annually compile a list of high-income countries based on official statistics of the International Bank for Reconstruction and Development of the World Bank. Based on that list, the negotiator must submit a report describing (1) such countries' actions and impacts relating to the pharmaceutical trade, and (2) the current status of any responsive actions taken by the United States.

The bill also requires the USTR to submit to Congress a plan to respond to certain adverse acts, policies, or practices of high-income countries that are related to the trade of pharmaceutical products.

Show official title

To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 4780’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Jodey C. Arrington (R-TX-19)
Cosponsors
8 cosponsors

4 original · 4 later

8 R

  1. Rep. Vern Buchanan (R-FL-16)· Original · Jul 29, 2025
  2. Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Original · Jul 29, 2025
  3. Rep. Gregory F. Murphy (R-NC-3)· Original · Jul 29, 2025
  4. Rep. Claudia Tenney (R-NY-24)· Original · Jul 29, 2025
  5. Rep. Carol D. Miller (R-WV-1)· Later · Aug 5, 2025
  6. Rep. James R. Baird (R-IN-4)· Later · Mar 27, 2026
  7. Rep. Nathaniel Moran (R-TX-1)· Later · Apr 20, 2026
  8. Rep. W. Gregory Steube (R-FL-17)· Later · Jul 21, 2026
Policy area
Foreign Trade and International Finance

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Ways and Means.

    Sources

Committees

  1. HouseWays and MeansReferred Jul 29, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. USTRx Act

    Display title, Short title · Introduced in House

  2. Use Sovereignty To reduce Rx Act

    Short title · Introduced in House

  3. To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.

    Official title · Introduced in House